免疫組學公司
US ˙ NasdaqCM ˙ US45257U1088

SecurityIMNM / Immunome, Inc.
InstitutionMorgan Stanley
Latest Disclosed Ownership2,841,589 shares
Latest Disclosed Value $ 62,145,575
Morgan Stanley reports 66.26% increase in ownership of IMNM / Immunome, Inc.

On May 15, 2026 - Morgan Stanley filed a 13F-HR form disclosing ownership of 2,841,589 shares of Immunome, Inc. (US:IMNM) valued at $62,145,551 USD as of March 31, 2026. The entity filed a previous 13F-HR/A on May 27, 2026 disclosing 1,709,089 shares of Immunome, Inc.. This represents a change in shares of 66.26% during the quarter. The current value of the position is $55,922,472 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F IMMUNOME COM 45257U108 2,841,589 1,132,500 66.26 62,146 69.28 0.0037
2026-05-27 2025-12-31 13F/A-1 IMMUNOME COM 45257U108 1,709,089 -124,729 -6.80 36,711 70.96 0.0022
2026-02-13 2025-12-31 13F IMMUNOME COM 45257U108 1,709,089 -124,729 36,711
2026-05-27 2025-09-30 13F/A-1 IMMUNOME COM 45257U108 1,833,818 1,429,461 353.51 21,474 471.12 0.0013
2025-11-14 2025-09-30 13F IMMUNOME COM 45257U108 1,833,818 1,429,461 21,474 0.0013
2025-08-15 2025-06-30 13F IMMUNOME COM 45257U108 404,357 -459,866 -53.21 3,761 -35.35 0.0002
2025-05-15 2025-03-31 13F IMMUNOME COM 45257U108 864,223 465,356 116.67 5,816 37.33 0.0004
2025-05-15 2024-12-31 13F/A-1 IMMUNOME COM 45257U108 398,867 109,789 37.98 4,236 0.21 0.0003
2025-02-14 2024-12-31 13F IMMUNOME COM 45257U108 398,867 109,789 4,236 0.0003
2025-05-14 2024-09-30 13F/A-2 IMMUNOME COM 45257U108 289,078 -82,880 -22.28 4,226 -6.09 0.0003
2025-02-14 2024-09-30 13F/A-1 IMMUNOME COM 45257U108 289,078 -82,880 4,226 0.0003
2024-11-14 2024-09-30 13F IMMUNOME COM 45257U108 289,078 -82,880 4,226 0.0000
2025-05-14 2024-06-30 13F/A-2 IMMUNOME COM 45257U108 371,958 222,561 148.97 4,501 22.05 0.0003
2024-10-17 2024-06-30 13F/A-1 IMMUNOME COM 45257U108 371,958 222,561 4,501 0.0003
2024-08-14 2024-06-30 13F IMMUNOME COM 45257U108 371,958 222,561 4,501 0.0003
2024-10-17 2024-03-31 13F/A-2 IMMUNOME COM 45257U108 149,397 137,242 1,129.10 3,687 2,736.15 0.0003
2024-08-16 2024-03-31 13F/A-1 IMMUNOME COM 45257U108 149,397 137,242 3,687 0.0000
2024-05-15 2024-03-31 13F IMMUNOME COM 45257U108 149,397 137,242 3,687 0.0003
2024-08-16 2023-12-31 13F/A-1 IMMUNOME COM 45257U108 12,155 0 0.00 130 28.71 0.0000
2024-02-13 2023-12-31 13F IMMUNOME COM 45257U108 12,155 0 130 0.0000
2023-11-15 2023-09-30 13F IMMUNOME COM 45257U108 12,155 -1,311 -9.74 101 -4.72 0.0000
2023-08-14 2023-06-30 13F IMMUNOME COM 45257U108 13,466 1,336 11.01 107 76.67 0.0000
2023-05-15 2023-03-31 13F IMMUNOME COM 45257U108 12,130 0 0.00 61 130.77 0.0000
2023-02-14 2022-12-31 13F IMMUNOME COM 45257U108 12,130 -4 -0.03 27 -50.94 0.0000
2022-11-14 2022-09-30 13F IMMUNOME COM 45257U108 12,134 -796 -6.16 53 29.27 0.0000
2022-10-27 2022-06-30 13F/A-1 IMMUNOME COM 45257U108 12,930 -802 -5.84 41 -47.44 0.0000
2022-08-15 2022-06-30 13F IMMUNOME COM 45257U108 12,930 -802 41 0.0000
2022-10-27 2022-03-31 13F/A-1 IMMUNOME COM 45257U108 13,732 -64,983 -82.55 78 -92.35 0.0000
2022-05-13 2022-03-31 13F IMMUNOME COM 45257U108 13,732 -64,983 78 0.0000
2022-02-14 2021-12-31 13F IMMUNOME COM 45257U108 78,715 64,629 458.82 1,020 197.38 0.0001
2021-11-15 2021-09-30 13F IMMUNOME COM 45257U108 14,086 2,715 23.88 343 75.00 0.0000
2021-08-23 2021-06-30 13F/A-1 IMMUNOME COM 45257U108 11,371 11,251 9,375.83 196 4,800.00 0.0000
2021-08-16 2021-06-30 13F IMMUNOME COM 45257U108 11,371 11,251 196 0.0000
2021-05-17 2021-03-31 13F IMMUNOME COM 45257U108 120 -2,128 -94.66 4 -81.82 0.0000
2021-02-16 2020-12-31 13F IMMUNOME COM 45257U108 2,248 2,248 22 0.0000
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.